08:00 - 08:30
Arrival and registration
08:30 - 09:00
Official opening
09:00 - 10:30
Capacity-building through competencies for the substance use workforce
09:00 - 10:30
Plenary session 1
10:30 - 10:50
Coffee break
10:30 - 18:20
e-poster session day 1
10:30 - 18:20
e-short communication session day 1
10:50 - 12:20
Advances in drug treatment
10:50 - 12:20
Advancing addiction research: global perspectives and collaborative initiatives
10:50 - 12:20
Alcohol: policy and harm reduction
10:50 - 12:20
Building addiction workforce capacity
10:50 - 12:20
Cannabis legalisation in Canada and the US: policy variation, state of the evidence and ideas for future research
10:50 - 12:20
ECR Programme — Scientific writing
10:50 - 12:20
Evaluation of drug consumption rooms: guidance step by step
10:50 - 12:20
Gambling: work-related, financial, and criminological issues
10:50 - 12:20
Innovative health approaches
10:50 - 12:20
Lives at risk: mental health and substance use
10:50 - 12:20
Mechanisms and outcomes in substance use prevention among youth
10:50 - 12:20
Prevalence of opioids and related harms
10:50 - 12:20
Sex, gender and diversity in drugs
10:50 - 12:20
Support for recovery
10:50 - 12:20
Treatment of alcohol use disorder
12:20 - 13:20
Lunch break
13:20 - 14:50
Alcohol use disorder: clinical biology and epidemiology
13:20 - 14:50
Alcohol use in the young
13:20 - 14:50
Challenge of measuring use and impact of cannabinoids
13:20 - 14:50
Drug policy and the criminal legal system
13:20 - 14:50
Enhancing access to harm reduction services in community and prisons: experiences of translating policy into practice and scaling interventions
13:20 - 14:50
Gender and substance use
13:20 - 14:50
Learning from Africa: workforce development, enhancement and support
13:20 - 14:50
Legal Shifts and Their Impact on Drug Use and Sentencing
13:20 - 14:50
Meetings the needs of women who use drugs or alcohol
13:20 - 14:50
Methods and measurement
13:20 - 14:50
Neurocognitive processes in behavioural addictions
13:20 - 14:50
Neuroscience and cognition
13:20 - 14:50
Substance use interventions in youth
13:20 - 14:50
The peer model: the critical role of ethics in efficacy
13:20 - 14:50
Tobacco, mental health and other substance use
13:20 - 14:50
Workshop on conducting drug research in prison: Challenges and key recommendations from the European experience
15:00 - 16:30
Alcohol use from brief intervention to harm reduction
15:00 - 16:30
Assessment of behavioural addictions
15:00 - 16:30
Challenges in community-based prevention
15:00 - 16:30
Conceptualising health and harms
15:00 - 16:30
Inequalities and needs of migrant groups
15:00 - 16:30
Infectious diseases in people who inject drugs
15:00 - 16:30
LEGO® SERIOUS PLAY® facilitated workshop optimal workplace and wellbeing in workers in addictions fields
15:00 - 16:30
Measuring drug market phenomenon
15:00 - 16:30
Problematic gambling and gaming
15:00 - 16:30
Quality in addictions work systems
15:00 - 16:30
Responses to behavioural addictions
15:00 - 16:30
Substance use and psychosis
15:00 - 16:30
Surveillance of drug-related morbidity and mortality
15:00 - 16:30
The growing threat of synthetic drugs – developments and responses in North America and Europe
15:00 - 16:30
The recovery journey
15:00 - 16:30
Trauma and addiction - developing skills in the screening of traumatic experiences in addiction care
15:00 - 16:30
WAVE Cine Video contest session 1
16:30 - 16:50
Coffee break
16:50 - 18:20
Decriminalisation and alternatives to arrest
16:50 - 18:20
Drug use trends
16:50 - 18:20
Hepatitis C, HIV, and other drug related harms
16:50 - 18:20
Motivations for use
16:50 - 18:20
Novel and contextual approaches in prevention
16:50 - 18:20
NPS: Trends, Concerns and Response Strategies
16:50 - 18:20
Opioid treatment 1
16:50 - 18:20
Opioids: trends, use and treatments
16:50 - 18:20
Psychedelics 1
16:50 - 18:20
Showcasing AI and digital workforce support
16:50 - 18:20
Strengthening quality in substance use disorders treatment
16:50 - 18:20
The EUFAS-EAR European Addiction Research Award
16:50 - 18:20
Understanding interrelationships: mental health and substance use
18:30 - 19:30
Why are we not doing better at reducing drug-related deaths?
09:00 - 10:30
Expert knowledge elicitation to complement and enhance data collection and monitoring efforts.
09:00 - 10:30
Plenary session 2
10:30 - 10:50
Coffee break
10:30 - 18:20
e-poster session day 2
10:30 - 18:20
e-short communication session day 2
10:50 - 12:20
Foresight workshop on workforce development and new professional profiles in times of HR shortages
10:50 - 12:20
Challenges, threats, and opportunities in addiction publishing today
10:50 - 12:20
Contemporary issues
10:50 - 12:20
ECR: An introduction to theory in qualitative research
10:50 - 12:20
Emerging drug harms, DCRs and other responses
10:50 - 12:20
EU research funding opportunities
10:50 - 12:20
Evidence informed drug and alcohol policy
10:50 - 12:20
Innovative methods for understanding drug markets and policy
10:50 - 12:20
International collaboration to understand and address the co-occurrence of addiction with ADHD and autism spectrum disorders
10:50 - 12:20
Natural language processing for addiction research: a practical primer
10:50 - 12:20
Opioid Agonist Treatment: novel formulations and challenges
10:50 - 12:20
Opioid treatment 2
10:50 - 12:20
Predicting the future: biomarkers for progression of alcohol use disorder
10:50 - 12:20
ScaleUp: Options for scalable psychosocial and pharmacological treatment of stimulant use disorder
10:50 - 12:20
The challenges of the digital era: an interdisciplinary investigation of screen time and social media.
10:50 - 12:20
Workers reaching marginalised groups
12:20 - 13:20
Lunch break
13:20 - 14:50
Co-creating robust systems with workers
13:20 - 14:50
Conceptual frameworks for studying drug policy
13:20 - 14:50
EUFAS General assembly
13:20 - 14:50
European prevention curriculum: increasing the use of evidence-based prevention
13:20 - 14:50
New opportunities for informing clinical practice and policy development in the area of behavioural addictions
13:20 - 14:50
Nitazene-related fatal and non-fatal toxicity in Europe: hospital emergency perspective
13:20 - 14:50
Novel neurobiology - cannabis, cognition and craving
13:20 - 14:50
Pregnancy, drug use and care
13:20 - 14:50
Public health and safety impacts of cannabis legalization in Canada: five years in review
13:20 - 14:50
Scenarios for the future of addictions fields by 2040
13:20 - 14:50
Understanding drug-related deaths
13:20 - 14:50
Understanding harm reduction: economic, social, and health perspectives
13:20 - 14:50
WAVE Cine Video contest session 1
13:20 - 14:50
Women's realities of drug use
13:20 - 14:50
Writing for 'addiction' journals for early career researchers with DEPP Editors-in-Chief
13:20 - 14:50
Young people, mental health and substance use
15:00 - 16:30
A unique care model for inpatient addictions and tri-morbidity within an acute UK hospital
15:00 - 16:30
Alcohol epidemiology: social inequalities
15:00 - 16:30
Cannabis legalisation — models and impacts
15:00 - 16:30
City insights: creating a collaborative network for city-level monitoring of drug trends and harm reduction
15:00 - 16:30
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
15:00 - 16:30
From genes to brains
15:00 - 16:30
Hepatitis C testing and treatment
15:00 - 16:30
How can treatment be a better experience?
15:00 - 16:30
How to respond to real-time drug alerts in European countries ?
15:00 - 16:30
How to train an addiction specialist?
15:00 - 16:30
New perspectives: AI as a tool to support the addictions workforce
15:00 - 16:30
Novel psychoactive substances and latest drug trends in Asia and Pacific countries
15:00 - 16:30
NPS: Pharmacological Characterization and Substance Analysis
15:00 - 16:30
Policy issues in gambling
15:00 - 16:30
Protective and risk factors in drug prevention
15:00 - 16:30
The hepatitis C endgame: Science, Policy, Politics
16:30 - 16:50
Coffee break
16:50 - 18:20
A two-phased augmentation/intervention extension of Claremont’s media-based prevention education model
16:50 - 18:20
Alcohol and gender issues
16:50 - 18:20
Alcohol use among the elderly
16:50 - 18:20
Behavioural addictions, prevention and theory
16:50 - 18:20
From old to new: changes in drug use
16:50 - 18:20
Hospital-based treatments
16:50 - 17:50
How can the voices of people with lived experience, clients and communities impacted by drug use better inform clinical practice, research and the policy agenda?
16:50 - 18:20
Internet, smartphones and social media use
16:50 - 18:20
Misuse of medicines
16:50 - 18:20
Mixed methods for understanding drug use
16:50 - 18:20
New Research on Alcohol and Tobacco Policy
16:50 - 18:20
Newly Regulated Markets, Managing Harms, Treatment & Advocating for Reform
16:50 - 18:20
Substance use and mental health in treatment settings
16:50 - 18:20
Toolkit to Deal with Female Drug User Victims of Gender-Based Violence
16:50 - 18:20
Viral hepatitis among people who inject drugs
17:50 - 18:20
EUDA presentation
09:00 - 10:30
A comparative discussion on the role, challenges, and opportunities for addiction nurses within Europe.
09:00 - 10:30
Plenary session 3
10:30 - 10:50
Coffee break
10:30 - 14:50
e-poster session day 3
10:30 - 14:50
e-short communication session day 3
10:50 - 12:20
Alcohol: interventions and up-to-date technologies
10:50 - 12:20
Drugs checking services
10:50 - 12:20
ECR Programme - EU research funding opportunities
10:50 - 12:20
Emerging challenges in drug markets: monitoring, measurement & impacts
10:50 - 12:20
Gaming and health
10:50 - 12:20
Gaming and social media use
10:50 - 12:20
How can cannabis policy goals inform the development of evaluation indicators?
10:50 - 12:20
Intentional and non-intentional drug-related deaths
10:50 - 12:20
Intimate partner violence perpetration: The ADVANCE-Digital Programme for men
10:50 - 12:20
Online monitoring
10:50 - 12:20
Psychedelics 2
10:50 - 12:20
Substance use and treatment needs across European prisons
10:50 - 12:20
Support for diverse workers in addictions
10:50 - 12:20
The ripple effect: International developments in the opioid market and their potential implications for European public health and security
10:50 - 12:20
Trauma and substance use
10:50 - 12:20
Unravelling the nexus: understanding drug-related violence across Europe
10:50 - 12:20
WAVE Cine Video contest session 2
12:20 - 13:20
Lunch break
13:20 - 14:50
Addressing diverse treatment needs
13:20 - 14:50
Alcohol and other drug policies in the work setting – a perspective on European developments
13:20 - 14:50
Findings from The Lancet Public Health Commission on Gambling: protecting the public from gambling harms
13:20 - 14:50
Future of opioid markets in Europe: Foresight approaches.
13:20 - 14:50
Holistic care for mental well-being
13:20 - 14:50
Impact of drug policy on drug production & markets
13:20 - 14:50
Overdose prevention
13:20 - 14:50
Prevention and addiction in underrepresented groups
13:20 - 14:50
Regulating cannabis supply policies in Europe: navigating the long road to change
13:20 - 14:50
Research into practice: The implementation and evaluation of alcohol assertive outreach treatment in England
13:20 - 14:50
Substance use and mental health in prison settings
13:20 - 14:50
Young people and drugs
15:00 - 16:50
Closing session